HEARD ON THE FLOOR AT ABLC: BioVeritas takes a giant leap towards commercialization
ABLC is buzzing about BioVeritas, which tipped this morning that it has initiated the second phase of Front-End-Loading (FEL-2) for its first commercial production facility, which is targeted for commissioning in 2026. If you are an engineer of the physical world, probably enough said right there. You’d already know that FEL-2 is the Rubicon, stepping […]









